1. 1468PGECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC. (23rd October 2018) Authors: Majem Tarruella, M; Campillo, J; Grau Béjar, J F; Carcereny, E; Bernabe Caro, R; Garcia, Y; Artal-Cortes, A; González Cao, M; Lianes, P; Paredes Lario, A; Sereno Moyano, M; Mielgo Rubio, X; Macias, J A; Provencio Pulla, M; Rodriguez-Abreu, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 509PSecond-line treatment after first-line vinorelbine in advanced platinum unfit NSCLC patients: An exploratory analysis of randomized Tempo-Lung trial. (24th November 2019) Authors: Camerini, A; Morabito, A; Montanino, A; Bernabe Caro, R; Grossi, F; Ramlau, R; Ciuleanu, T-E; Ceresoli, G L; Pasello, G; de Marinis, F; Bosch-Barrera, J; Landreau, P; Gautier, S; Ta Thanh Minh, C; Kowalski, D Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗